Cargando…

Divergent effects of vitamins K1 and K2 on triple negative breast cancer cells

Vitamin K serves as an essential co-factor in the γ-carboxylation of glutamate to γ-carboxyglutamate (GLA), a post-translational modification mediated by gamma-glutamyl carboxylase (GGCX) and vitamin K oxidoreductases (VKORC1 or VKORC1L1). While both phylloquinone (K1) and menaquinone (K2) support t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beaudin, Sarah, Kokabee, Leila, Welsh, JoEllen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481349/ https://www.ncbi.nlm.nih.gov/pubmed/31040920 http://dx.doi.org/10.18632/oncotarget.26765

Ejemplares similares

The impact of vitamin D in breast cancer: genomics, pathways, metabolism
por: Narvaez, Carmen J., et al.
Publicado: (2014)

Vitamin D and Breast Cancer: Mechanistic Update
por: Welsh, JoEllen
Publicado: (2021)

Vitamin C sensitizes triple negative breast cancer to PI3K inhibition therapy
por: Mustafi, Sushmita, et al.
Publicado: (2021)

Inhibition of HAS2 and hyaluronic acid production by 1,25-Dihydroxyvitamin D(3) in breast cancer
por: Narvaez, Carmen J., et al.
Publicado: (2020)

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer
por: Rajput, Sandeep, et al.
Publicado: (2019)

H3K27me3 conditions chemotolerance in triple-negative breast cancer
por: Marsolier, Justine, et al.
Publicado: (2022)

BCATc modulates crosstalk between the PI3K/Akt and the Ras/ERK pathway regulating proliferation in triple negative breast cancer
por: Shafei, Mai Ahmed, et al.
Publicado: (2020)

Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer
por: Prvanović, Mirjana, et al.
Publicado: (2021)

Vitamin C supplementation expands the therapeutic window of BETi for triple negative breast cancer
por: Mustafi, Sushmita, et al.
Publicado: (2019)

Bruton’s Tyrosine Kinase and Its Isoforms in Cancer
por: Wang, Xianhui, et al.
Publicado: (2021)

Introduction: Special Issue on Vitamin D Dedicated to the Memory of Anthony W Norman
por: Bouillon, Roger, et al.
Publicado: (2020)

DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer
por: Yang, Yang, et al.
Publicado: (2017)

Control of TCF-4 Expression by VDR and Vitamin D in the Mouse Mammary Gland and Colorectal Cancer Cell Lines
por: Beildeck, Marcy E., et al.
Publicado: (2009)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer
por: Lee, Chanju, et al.
Publicado: (2022)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Vitamin K
por: Shea, M Kyla, et al.
Publicado: (2021)

Thioguanine Induces Apoptosis in Triple-Negative Breast Cancer by Regulating PI3K–AKT Pathway
por: Zhang, Daoyu, et al.
Publicado: (2020)

ERRα regulates the growth of triple-negative breast cancer cells via S6K1-dependent mechanism
por: Berman, Adi Y, et al.
Publicado: (2017)

Over-expression of hedgehog signaling is associated with epidermal tumor formation in vitamin D receptor null mice
por: Teichert, Arnaud, et al.
Publicado: (2011)

Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts
por: Coussy, Florence, et al.
Publicado: (2020)

A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment
por: Alcaraz, Lindsay B, et al.
Publicado: (2021)

Anti-Cancer Effects of Sulfasalazine and Vitamin E Succinate in MDA-MB 231 Triple-Negative Breast Cancer Cells
por: Wei, Chyou-Wei, et al.
Publicado: (2019)

NDRG1 regulates neutral lipid metabolism in breast cancer cells
por: Sevinsky, Christopher J., et al.
Publicado: (2018)

Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway
por: Massihnia, Daniela, et al.
Publicado: (2016)

Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
por: Xu, Yonggang, et al.
Publicado: (2021)

Abrogating Metastatic Properties of Triple-Negative Breast Cancer Cells by EGFR and PI3K Dual Inhibitors
por: Garcia, Ana Rita, et al.
Publicado: (2023)

PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer
por: Amante, Romain J., et al.
Publicado: (2023)

Prognostic significance of GSTP1 in patients with triple negative breast cancer
por: Chen, Guanglei, et al.
Publicado: (2017)

Vitamin K: an old vitamin in a new perspective
por: Gröber, U, et al.
Publicado: (2015)

The Role of Vitamin D and Vitamin D Receptor in Immunity to Leishmania major Infection
por: Whitcomb, James P., et al.
Publicado: (2012)

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
por: Thakkar, A., et al.
Publicado: (2016)

Vitamin D in Triple-Negative and BRCA1-Deficient Breast Cancer—Implications for Pathogenesis and Therapy
por: Blasiak, Janusz, et al.
Publicado: (2020)

VITAMIN K ANTAGONISM AND CHONDROCALCINOSIS IN THE OSTEOARTHRITIS INITIATIVE
por: Shea, M Kyla, et al.
Publicado: (2019)

Comparison of clinical and magnetic resonance imaging findings of triple-negative breast cancer with non-triple-negative tumours
por: Yetkin, Duygu İmre, et al.
Publicado: (2021)

Vitamin K Metabolism and Vitamin K-Dependent Proteins
por: Levinson, Barry L.
Publicado: (1980)

Vitamin K2 Needs an RDI Separate from Vitamin K1
por: Akbulut, Asim Cengiz, et al.
Publicado: (2020)

Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer
por: Solzak, Jeffrey P., et al.
Publicado: (2017)

Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer
por: Johnson, Jeremy, et al.
Publicado: (2020)

Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models
por: Guo, Zhanfang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bfjeoiv2rc680k8rac7u6c2qvp